Oncolytics Biotech Ownership | Who Owns Oncolytics Biotech?


OverviewForecastChartTranscripts

Oncolytics Biotech Ownership Summary


Oncolytics Biotech is owned by 1.76% institutional investors, 3.61% insiders, and 94.63% retail investors. Seeds investor is the largest institutional shareholder, holding 0.25% of ONCY shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.07% of its assets in Oncolytics Biotech shares.

ONCY Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOncolytics Biotech1.76%3.61%94.63%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Seeds investor189.94K0.25%$173.57K
International assets investment management206.90K0.24%$159.93K
Morgan stanley138.52K0.18%$137.14K
Citadel advisors137.09K0.18%$135.71K
Goldman sachs group101.40K0.13%$92.66K
Geode capital management66.94K0.09%$61.17K
Royal bank of canada63.68K0.08%$58.00K
Commonwealth equity services60.11K0.08%$55.00K
Cibc world market60.38K0.07%$46.15K
Headinvest44.83K0.05%$34.66K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Seeds investor189.94K0.05%$173.57K
International assets investment management206.90K0.01%$159.93K
Headinvest44.83K0.01%$34.66K
Brave asset management25.00K0.01%$23.12K
Rovin capital /ut/ /adv20.62K0.01%$19.00K
Newman dignan & sheerar22.91K0.00%$17.71K
Seacrest wealth management32.00K0.00%$24.74K
Professional advisory services20.00K0.00%$15.00K
Cedar mountain advisors5.65K0.00%$5.16K
C2p capital advisory group, llc d.b.a. prosperity capital advisors15.00K0.00%$11.60K

Top Buyers

HolderShares% AssetsChange
Geode capital management66.94K-25.00K
National bank of canada /fi/24.66K-20.00K
Headinvest44.83K0.01%20.00K
Goldman sachs group101.40K-16.40K
Pnc financial services group15.05K-15.05K

Top Sellers

HolderShares% AssetsChange
Morgan stanley138.52K--209.79K
Virtu financial---98.45K
Millennium management---40.89K
Long focus capital management---40.00K
Citadel advisors137.09K--25.68K

New Positions

HolderShares% AssetsChangeValue
Pnc financial services group15.05K-15.05K$13.76K
Toronto dominion bank12.91K-12.91K$9.86K
Franklin resources12.67K-12.67K$11.70K
Xtx topco12.63K0.00%12.63K$9.76K
Cerity partners10.00K-10.00K$7.73K

Sold Out

HolderChange
Pacifica partners-100.00
Beaird harris wealth management-825.00
Steward partners investment advisory-1.00K
Principal securities-3.00K
Tower research capital llc (trc)-7.72K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20255512.24%1,492,51810.47%155.94%239.52%5-28.57%
Mar 31, 2025508.70%1,365,5173.85%160.09%22-8.33%7-
Dec 31, 202427-35.71%736,398-38.42%-39.18%14-2-77.78%
Sep 30, 202441-1,193,430-8.85%151.80%14-22.22%912.50%
Jun 30, 20244117.14%1,309,286-7.29%147.43%1828.57%8-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index66.94K0.07%-
Vifag 2002 SICAV30.00K0.04%-

ONCY Ownership FAQ


Who Owns Oncolytics Biotech?

Oncolytics Biotech shareholders are primarily institutional investors at 1.76%, followed by 3.61% insiders and 94.63% retail investors. The average institutional ownership in Oncolytics Biotech's industry, Biotech Stocks , is 306.59%, which Oncolytics Biotech falls below.

Who owns the most shares of Oncolytics Biotech?

Oncolytics Biotech’s largest shareholders are Seeds investor (189.94K shares, 0.25%), International assets investment management (206.9K shares, 0.24%), and Morgan stanley (138.52K shares, 0.18%). Together, they hold 0.68% of Oncolytics Biotech’s total shares outstanding.

Does Blackrock own Oncolytics Biotech?

BlackRock is not among the top 10 institutional shareholders of Oncolytics Biotech.

Who is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested?

Seeds investor is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 189.94K Oncolytics Biotech shares, valued at 173.57K$.

Who is the top mutual fund holder of Oncolytics Biotech shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Oncolytics Biotech shares, with 0.07% of its total shares outstanding invested in 66.94K Oncolytics Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools